Skip to main content
Premium Trial:

Request an Annual Quote

And Speaking of Lack of Consumer Education...

This article in the Wall Street Journal describes Myriad Genetics' consumer-targeted ad campaign for the BRCA1 and BRCA2 tests and the ensuing debate about "who really needs the test and whether it will induce low-risk women to take drastic measures to prevent the disease," the story says. "That can mean more frequent screenings and taking certain preventive drugs, but also can include prophylactic surgical removal of a woman's breasts or ovaries." (Bet they don't mention that in the ads.)


The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.